The Impact of Cytochrome P450 Abnormalities in Patients With Delirium.

Completed

Conditions studied: Delirium, Cytochrome P-450 Enzyme System

In brief

Objectives: 1. To examine whether patients with delirium have higher prevalence of cytochrome-P450 abnormalities compared to patients without delirium. 2. To examine whether the severity of delirium is related to a specific cytochrome P450 genotype. 3. To examine the persistence of delirium at 6-8 weeks stratified by presence of cytochrome p450 abnormalities 4. To examine whether delirium persistence is impacted by types of medications administered during their hospital stay.

Key facts

Study ID
NCT03829670
Run by
Wake Forest University Health Sciences
People needed
13
Starts
2019-01-31
Expected to finish
2020-06-24
Last updated by the study team
2024-10-04

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.